#METABOLOMICS WORKBENCH jli_20210217_034113 DATATRACK_ID:2491 STUDY_ID:ST001707 ANALYSIS_ID:AN002781 PROJECT_ID:PR001092
VERSION             	1
CREATED_ON             	February 22, 2021, 2:18 pm
#PROJECT
PR:PROJECT_TITLE                 	Lipid Profiling of Mouse Intestinal Organoids for studying APC Mutations
PR:PROJECT_SUMMARY               	Inactivating mutations including both germline and somatic mutations in the
PR:PROJECT_SUMMARY               	adenomatous polyposis coli (APC) gene drives most familial and sporadic
PR:PROJECT_SUMMARY               	colorectal cancers. Understanding the metabolic implications of this mutation
PR:PROJECT_SUMMARY               	will aid to establish its wider impact on cellular behaviour and potentially
PR:PROJECT_SUMMARY               	inform clinical decisions. However, to date, alterations in lipid metabolism
PR:PROJECT_SUMMARY               	induced by APC mutations remain unclear. Intestinal organoids have gained
PR:PROJECT_SUMMARY               	widespread popularity in studying colorectal cancer and chemotherapies, because
PR:PROJECT_SUMMARY               	their three-dimensional structure more accurately mimics an in vivo environment.
PR:PROJECT_SUMMARY               	Here, we aimed to investigate intra-cellular lipid disturbances induced by APC
PR:PROJECT_SUMMARY               	gene mutations in intestinal organoids using a reversed-phase
PR:PROJECT_SUMMARY               	ultra-high-performance liquid chromatography mass spectrometry
PR:PROJECT_SUMMARY               	(RP-UHPLC-MS)-based lipid profiling method. Lipids of the organoids grown from
PR:PROJECT_SUMMARY               	either wildtype (WT) or mice with Apc mutations (Lgr5–EGFP-IRES-CreERT2
PR:PROJECT_SUMMARY               	Apcfl/fl) were extracted and analysed using RP-UHPLC-MS. Concentrations of
PR:PROJECT_SUMMARY               	phospholipids (e.g. PC(16:0/16:0), PC(18:1/20:0), PC(38:0), PC(18:1/22:1)),
PR:PROJECT_SUMMARY               	ceramides (e.g. Cer(d18:0/22:0), Cer(d42:0), Cer(d18:1/24:1)) and
PR:PROJECT_SUMMARY               	hexosylceramide (e.g. HexCer(d18:1/16:0), HexCer(d18:1/22:0)) were higher in
PR:PROJECT_SUMMARY               	Apcfl/fl organoids, whereas levels of sphingomyelins (e.g. SM(d18:1/14:0),
PR:PROJECT_SUMMARY               	SM(d18:1/16:0) ) were lower compared to WT. These observations indicate that
PR:PROJECT_SUMMARY               	cellular metabolism of sphingomyelin was upregulated, resulting in the cellular
PR:PROJECT_SUMMARY               	accumulation of ceramides and production of HexCer due to the absence of
PR:PROJECT_SUMMARY               	Apcfl/fl in the organoids. Our observations demonstrated lipid profiling of
PR:PROJECT_SUMMARY               	organoids and provided an enhanced insight into the effects of the APC mutations
PR:PROJECT_SUMMARY               	on lipid metabolism, making for a valuable addition to screening options of the
PR:PROJECT_SUMMARY               	organoid lipidome.
PR:INSTITUTE                     	Imperial College London
PR:LAST_NAME                     	Li
PR:FIRST_NAME                    	Jia
PR:ADDRESS                       	Imperial College London Road, South Kensington, London, London, SW7 2AZ, United
PR:ADDRESS                       	Kingdom
PR:EMAIL                         	jia.li@imperial.ac.uk
PR:PHONE                         	02075943230
#STUDY
ST:STUDY_TITLE                   	Lipid Profiling of Mouse Intestinal Organoids for studying APC Mutations
ST:STUDY_SUMMARY                 	Inactivating mutations including both germline and somatic mutations in the
ST:STUDY_SUMMARY                 	adenomatous polyposis coli (APC) gene drives most familial and sporadic
ST:STUDY_SUMMARY                 	colorectal cancers. Understanding the metabolic implications of this mutation
ST:STUDY_SUMMARY                 	will aid to establish its wider impact on cellular behaviour and potentially
ST:STUDY_SUMMARY                 	inform clinical decisions. However, to date, alterations in lipid metabolism
ST:STUDY_SUMMARY                 	induced by APC mutations remain unclear. Intestinal organoids have gained
ST:STUDY_SUMMARY                 	widespread popularity in studying colorectal cancer and chemotherapies, because
ST:STUDY_SUMMARY                 	their three-dimensional structure more accurately mimics an in vivo environment.
ST:STUDY_SUMMARY                 	Here, we aimed to investigate intra-cellular lipid disturbances induced by APC
ST:STUDY_SUMMARY                 	gene mutations in intestinal organoids using a reversed-phase
ST:STUDY_SUMMARY                 	ultra-high-performance liquid chromatography mass spectrometry
ST:STUDY_SUMMARY                 	(RP-UHPLC-MS)-based lipid profiling method. Lipids of the organoids grown from
ST:STUDY_SUMMARY                 	either wildtype (WT) or mice with Apc mutations (Lgr5–EGFP-IRES-CreERT2
ST:STUDY_SUMMARY                 	Apcfl/fl) were extracted and analysed using RP-UHPLC-MS. Concentrations of
ST:STUDY_SUMMARY                 	phospholipids (e.g. PC(16:0/16:0), PC(18:1/20:0), PC(38:0), PC(18:1/22:1)),
ST:STUDY_SUMMARY                 	ceramides (e.g. Cer(d18:0/22:0), Cer(d42:0), Cer(d18:1/24:1)) and
ST:STUDY_SUMMARY                 	hexosylceramide (e.g. HexCer(d18:1/16:0), HexCer(d18:1/22:0)) were higher in
ST:STUDY_SUMMARY                 	Apcfl/fl organoids, whereas levels of sphingomyelins (e.g. SM(d18:1/14:0),
ST:STUDY_SUMMARY                 	SM(d18:1/16:0) ) were lower compared to WT. These observations indicate that
ST:STUDY_SUMMARY                 	cellular metabolism of sphingomyelin was upregulated, resulting in the cellular
ST:STUDY_SUMMARY                 	accumulation of ceramides and production of HexCer due to the absence of
ST:STUDY_SUMMARY                 	Apcfl/fl in the organoids. Our observations demonstrated lipid profiling of
ST:STUDY_SUMMARY                 	organoids and provided an enhanced insight into the effects of the APC mutations
ST:STUDY_SUMMARY                 	on lipid metabolism, making for a valuable addition to screening options of the
ST:STUDY_SUMMARY                 	organoid lipidome.
ST:INSTITUTE                     	Imperial College London
ST:LAST_NAME                     	Li
ST:FIRST_NAME                    	Jia
ST:ADDRESS                       	Imperial College London, UK
ST:EMAIL                         	jia.li@imperial.ac.uk
ST:PHONE                         	00442075943230
#SUBJECT
SU:SUBJECT_TYPE                  	Cultured cells
SU:SUBJECT_SPECIES               	Mus musculus
SU:TAXONOMY_ID                   	10090
#FACTORS
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	m1641	NEG_WT_m1641_1	Genotype:wildtype	RAW_FILE_NAME=NEG_WT_m1641_1; sample replicate IDs=1; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m1641	NEG_WT_m1641_2	Genotype:wildtype	RAW_FILE_NAME=NEG_WT_m1641_2; sample replicate IDs=2; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m1641	NEG_WT_m1641_3	Genotype:wildtype	RAW_FILE_NAME=NEG_WT_m1641_3; sample replicate IDs=3; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m1641	NEG_WT_m1641_4	Genotype:wildtype	RAW_FILE_NAME=NEG_WT_m1641_4; sample replicate IDs=4; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m1641	NEG_WT_m1641_5	Genotype:wildtype	RAW_FILE_NAME=NEG_WT_m1641_5; sample replicate IDs=5; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m1641	NEG_WT_m1641_6	Genotype:wildtype	RAW_FILE_NAME=NEG_WT_m1641_6; sample replicate IDs=6; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m1641	NEG_WT_m1641_7	Genotype:wildtype	RAW_FILE_NAME=NEG_WT_m1641_7; sample replicate IDs=7; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m1641	NEG_WT_m1641_8	Genotype:wildtype	RAW_FILE_NAME=NEG_WT_m1641_8; sample replicate IDs=8; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m1663	NEG_WT_m1663_1	Genotype:wildtype	RAW_FILE_NAME=NEG_WT_m1663_1; sample replicate IDs=1; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m1663	NEG_WT_m1663_2	Genotype:wildtype	RAW_FILE_NAME=NEG_WT_m1663_2; sample replicate IDs=2; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m1663	NEG_WT_m1663_3	Genotype:wildtype	RAW_FILE_NAME=NEG_WT_m1663_3; sample replicate IDs=3; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m1663	NEG_WT_m1663_4	Genotype:wildtype	RAW_FILE_NAME=NEG_WT_m1663_4; sample replicate IDs=4; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m1663	NEG_WT_m1663_5	Genotype:wildtype	RAW_FILE_NAME=NEG_WT_m1663_5; sample replicate IDs=5; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m1663	NEG_WT_m1663_6	Genotype:wildtype	RAW_FILE_NAME=NEG_WT_m1663_6; sample replicate IDs=6; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m1663	NEG_WT_m1663_7	Genotype:wildtype	RAW_FILE_NAME=NEG_WT_m1663_7; sample replicate IDs=7; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m1663	NEG_WT_m1663_8	Genotype:wildtype	RAW_FILE_NAME=NEG_WT_m1663_8; sample replicate IDs=8; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m830	NEG_APC_m830_1	Genotype:APC	RAW_FILE_NAME=NEG_APC_m830_1; sample replicate IDs=1; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m830	NEG_APC_m830_2	Genotype:APC	RAW_FILE_NAME=NEG_APC_m830_2; sample replicate IDs=2; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m830	NEG_APC_m830_3	Genotype:APC	RAW_FILE_NAME=NEG_APC_m830_3; sample replicate IDs=3; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m830	NEG_APC_m830_4	Genotype:APC	RAW_FILE_NAME=NEG_APC_m830_4; sample replicate IDs=4; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m830	NEG_APC_m830_5	Genotype:APC	RAW_FILE_NAME=NEG_APC_m830_5; sample replicate IDs=5; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m830	NEG_APC_m830_6	Genotype:APC	RAW_FILE_NAME=NEG_APC_m830_6; sample replicate IDs=6; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m830	NEG_APC_m830_7	Genotype:APC	RAW_FILE_NAME=NEG_APC_m830_7; sample replicate IDs=7; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m830	NEG_APC_m830_8	Genotype:APC	RAW_FILE_NAME=NEG_APC_m830_8; sample replicate IDs=8; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m862	NEG_APC_m862_1	Genotype:APC	RAW_FILE_NAME=NEG_APC_m862_1; sample replicate IDs=1; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m862	NEG_APC_m862_2	Genotype:APC	RAW_FILE_NAME=NEG_APC_m862_2; sample replicate IDs=2; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m862	NEG_APC_m862_3	Genotype:APC	RAW_FILE_NAME=NEG_APC_m862_3; sample replicate IDs=3; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m862	NEG_APC_m862_4	Genotype:APC	RAW_FILE_NAME=NEG_APC_m862_4; sample replicate IDs=4; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m862	NEG_APC_m862_5	Genotype:APC	RAW_FILE_NAME=NEG_APC_m862_5; sample replicate IDs=5; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m862	NEG_APC_m862_6	Genotype:APC	RAW_FILE_NAME=NEG_APC_m862_6; sample replicate IDs=6; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m862	NEG_APC_m862_7	Genotype:APC	RAW_FILE_NAME=NEG_APC_m862_7; sample replicate IDs=7; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m862	NEG_APC_m862_8	Genotype:APC	RAW_FILE_NAME=NEG_APC_m862_8; sample replicate IDs=8; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	quality control	NEG_QC1	Genotype:quality control	RAW_FILE_NAME=NEG_QC1; sample replicate IDs=quality control; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	quality control	NEG_QC2	Genotype:quality control	RAW_FILE_NAME=NEG_QC2; sample replicate IDs=quality control; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	quality control	NEG_QC3	Genotype:quality control	RAW_FILE_NAME=NEG_QC3; sample replicate IDs=quality control; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	quality control	NEG_QC4	Genotype:quality control	RAW_FILE_NAME=NEG_QC4; sample replicate IDs=quality control; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	quality control	NEG_QC5	Genotype:quality control	RAW_FILE_NAME=NEG_QC5; sample replicate IDs=quality control; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	blank	NEG_Blank	Genotype:blank	RAW_FILE_NAME=NEG_Blank; sample replicate IDs=blank; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	quality control dilutions	NEG_Dilution1_2_1	Genotype:quality control dilutions	RAW_FILE_NAME=NEG_Dilution1_2_1; sample replicate IDs=quality control dilutions; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	quality control dilutions	NEG_Dilution1_2_2	Genotype:quality control dilutions	RAW_FILE_NAME=NEG_Dilution1_2_2; sample replicate IDs=quality control dilutions; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	quality control dilutions	NEG_Dilution1_2_3	Genotype:quality control dilutions	RAW_FILE_NAME=NEG_Dilution1_2_3; sample replicate IDs=quality control dilutions; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	quality control dilutions	NEG_Dilution1_4_1	Genotype:quality control dilutions	RAW_FILE_NAME=NEG_Dilution1_4_1; sample replicate IDs=quality control dilutions; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	quality control dilutions	NEG_Dilution1_4_2	Genotype:quality control dilutions	RAW_FILE_NAME=NEG_Dilution1_4_2; sample replicate IDs=quality control dilutions; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	quality control dilutions	NEG_Dilution1_4_3	Genotype:quality control dilutions	RAW_FILE_NAME=NEG_Dilution1_4_3; sample replicate IDs=quality control dilutions; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	quality control dilutions	NEG_Dilution1_8_1	Genotype:quality control dilutions	RAW_FILE_NAME=NEG_Dilution1_8_1; sample replicate IDs=quality control dilutions; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	quality control dilutions	NEG_Dilution1_8_2	Genotype:quality control dilutions	RAW_FILE_NAME=NEG_Dilution1_8_2; sample replicate IDs=quality control dilutions; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	quality control dilutions	NEG_Dilution1_8_3	Genotype:quality control dilutions	RAW_FILE_NAME=NEG_Dilution1_8_3; sample replicate IDs=quality control dilutions; MS mode=negative
SUBJECT_SAMPLE_FACTORS           	m1641	POS_WT_m1641_1	Genotype:wildtype	RAW_FILE_NAME=POS_WT_m1641_1; sample replicate IDs=1; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m1641	POS_WT_m1641_2	Genotype:wildtype	RAW_FILE_NAME=POS_WT_m1641_2; sample replicate IDs=2; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m1641	POS_WT_m1641_3	Genotype:wildtype	RAW_FILE_NAME=POS_WT_m1641_3; sample replicate IDs=3; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m1641	POS_WT_m1641_4	Genotype:wildtype	RAW_FILE_NAME=POS_WT_m1641_4; sample replicate IDs=4; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m1641	POS_WT_m1641_5	Genotype:wildtype	RAW_FILE_NAME=POS_WT_m1641_5; sample replicate IDs=5; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m1641	POS_WT_m1641_6	Genotype:wildtype	RAW_FILE_NAME=POS_WT_m1641_6; sample replicate IDs=6; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m1641	POS_WT_m1641_7	Genotype:wildtype	RAW_FILE_NAME=POS_WT_m1641_7; sample replicate IDs=7; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m1641	POS_WT_m1641_8	Genotype:wildtype	RAW_FILE_NAME=POS_WT_m1641_8; sample replicate IDs=8; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m1663	POS_WT_m1663_1	Genotype:wildtype	RAW_FILE_NAME=POS_WT_m1663_1; sample replicate IDs=1; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m1663	POS_WT_m1663_2	Genotype:wildtype	RAW_FILE_NAME=POS_WT_m1663_2; sample replicate IDs=2; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m1663	POS_WT_m1663_3	Genotype:wildtype	RAW_FILE_NAME=POS_WT_m1663_3; sample replicate IDs=3; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m1663	POS_WT_m1663_4	Genotype:wildtype	RAW_FILE_NAME=POS_WT_m1663_4; sample replicate IDs=4; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m1663	POS_WT_m1663_5	Genotype:wildtype	RAW_FILE_NAME=POS_WT_m1663_5; sample replicate IDs=5; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m1663	POS_WT_m1663_6	Genotype:wildtype	RAW_FILE_NAME=POS_WT_m1663_6; sample replicate IDs=6; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m1663	POS_WT_m1663_7	Genotype:wildtype	RAW_FILE_NAME=POS_WT_m1663_7; sample replicate IDs=7; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m1663	POS_WT_m1663_8	Genotype:wildtype	RAW_FILE_NAME=POS_WT_m1663_8; sample replicate IDs=8; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m830	POS_APC_m830_1	Genotype:APC	RAW_FILE_NAME=POS_APC_m830_1; sample replicate IDs=1; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m830	POS_APC_m830_2	Genotype:APC	RAW_FILE_NAME=POS_APC_m830_2; sample replicate IDs=2; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m830	POS_APC_m830_3	Genotype:APC	RAW_FILE_NAME=POS_APC_m830_3; sample replicate IDs=3; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m830	POS_APC_m830_4	Genotype:APC	RAW_FILE_NAME=POS_APC_m830_4; sample replicate IDs=4; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m830	POS_APC_m830_5	Genotype:APC	RAW_FILE_NAME=POS_APC_m830_5; sample replicate IDs=5; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m830	POS_APC_m830_6	Genotype:APC	RAW_FILE_NAME=POS_APC_m830_6; sample replicate IDs=6; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m830	POS_APC_m830_7	Genotype:APC	RAW_FILE_NAME=POS_APC_m830_7; sample replicate IDs=7; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m830	POS_APC_m830_8	Genotype:APC	RAW_FILE_NAME=POS_APC_m830_8; sample replicate IDs=8; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m862	POS_APC_m862_1	Genotype:APC	RAW_FILE_NAME=POS_APC_m862_1; sample replicate IDs=1; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m862	POS_APC_m862_2	Genotype:APC	RAW_FILE_NAME=POS_APC_m862_2; sample replicate IDs=2; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m862	POS_APC_m862_3	Genotype:APC	RAW_FILE_NAME=POS_APC_m862_3; sample replicate IDs=3; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m862	POS_APC_m862_4	Genotype:APC	RAW_FILE_NAME=POS_APC_m862_4; sample replicate IDs=4; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m862	POS_APC_m862_5	Genotype:APC	RAW_FILE_NAME=POS_APC_m862_5; sample replicate IDs=5; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m862	POS_APC_m862_6	Genotype:APC	RAW_FILE_NAME=POS_APC_m862_6; sample replicate IDs=6; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m862	POS_APC_m862_7	Genotype:APC	RAW_FILE_NAME=POS_APC_m862_7; sample replicate IDs=7; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	m862	POS_APC_m862_8	Genotype:APC	RAW_FILE_NAME=POS_APC_m862_8; sample replicate IDs=8; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	quality control	POS_QC1	Genotype:quality control	RAW_FILE_NAME=POS_QC1; sample replicate IDs=quality control; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	quality control	POS_QC2	Genotype:quality control	RAW_FILE_NAME=POS_QC2; sample replicate IDs=quality control; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	quality control	POS_QC3	Genotype:quality control	RAW_FILE_NAME=POS_QC3; sample replicate IDs=quality control; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	quality control	POS_QC4	Genotype:quality control	RAW_FILE_NAME=POS_QC4; sample replicate IDs=quality control; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	quality control	POS_QC5	Genotype:quality control	RAW_FILE_NAME=POS_QC5; sample replicate IDs=quality control; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	blank	POS_Blank	Genotype:blank	RAW_FILE_NAME=POS_Blank; sample replicate IDs=blank; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	quality control dilutions	POS_Dilution1_2_1	Genotype:quality control dilutions	RAW_FILE_NAME=POS_Dilution1_2_1; sample replicate IDs=quality control dilutions; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	quality control dilutions	POS_Dilution1_2_2	Genotype:quality control dilutions	RAW_FILE_NAME=POS_Dilution1_2_2; sample replicate IDs=quality control dilutions; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	quality control dilutions	POS_Dilution1_2_3	Genotype:quality control dilutions	RAW_FILE_NAME=POS_Dilution1_2_3; sample replicate IDs=quality control dilutions; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	quality control dilutions	POS_Dilution1_4_1	Genotype:quality control dilutions	RAW_FILE_NAME=POS_Dilution1_4_1; sample replicate IDs=quality control dilutions; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	quality control dilutions	POS_Dilution1_4_2	Genotype:quality control dilutions	RAW_FILE_NAME=POS_Dilution1_4_2; sample replicate IDs=quality control dilutions; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	quality control dilutions	POS_Dilution1_4_3	Genotype:quality control dilutions	RAW_FILE_NAME=POS_Dilution1_4_3; sample replicate IDs=quality control dilutions; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	quality control dilutions	POS_Dilution1_8_1	Genotype:quality control dilutions	RAW_FILE_NAME=POS_Dilution1_8_1; sample replicate IDs=quality control dilutions; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	quality control dilutions	POS_Dilution1_8_2	Genotype:quality control dilutions	RAW_FILE_NAME=POS_Dilution1_8_2; sample replicate IDs=quality control dilutions; MS mode=positive
SUBJECT_SAMPLE_FACTORS           	quality control dilutions	POS_Dilution1_8_3	Genotype:quality control dilutions	RAW_FILE_NAME=POS_Dilution1_8_3; sample replicate IDs=quality control dilutions; MS mode=positive
#COLLECTION
CO:COLLECTION_SUMMARY            	Control (Lgr5–EGFP-IRES-CreERT2 Apc+/+) or experimental
CO:COLLECTION_SUMMARY            	(Lgr5–EGFP-IRES-CreERT2 Apcfl/fl) adult mice were administered tamoxifen (80
CO:COLLECTION_SUMMARY            	mg/kg) daily via intraperitoneal injection for 4 consecutive days to induce Cre
CO:COLLECTION_SUMMARY            	expression. Fourteen days following induction mice were sacrificed (cervical
CO:COLLECTION_SUMMARY            	dislocation) and their intestinal cells were harvested for organoid culture of
CO:COLLECTION_SUMMARY            	WT or Apc deficient intestinal stem cells.
CO:SAMPLE_TYPE                   	Intestine
#TREATMENT
TR:TREATMENT_SUMMARY             	no treatment was applied
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Following aqueous extraction using cold methanol and water (v:v, 1:1), 1 ml of
SP:SAMPLEPREP_SUMMARY            	pre-chilled dichloromethane (DCM)/methanol (v:v, 3:1) was added to the organoid
SP:SAMPLEPREP_SUMMARY            	samples. Samples were bead-beaten for 40 seconds followed by five minutes of
SP:SAMPLEPREP_SUMMARY            	chilling on dry ice. This procedure was repeated three times before being
SP:SAMPLEPREP_SUMMARY            	centrifuged for 10 mins at 21,000 rcf at 4ºC. A total of 600 μl of supernatant
SP:SAMPLEPREP_SUMMARY            	from each sample was transferred to a glass vial. Another 200 μl of supernatant
SP:SAMPLEPREP_SUMMARY            	from each sample was pooled into a 15-ml Falcon tube to form a quantity control
SP:SAMPLEPREP_SUMMARY            	(QC) sample and split into several aliquots of 600 μl each. An extraction blank
SP:SAMPLEPREP_SUMMARY            	sample was included to control for any potential contaminant introduced
SP:SAMPLEPREP_SUMMARY            	throughout the extraction process. Samples were dried by evaporation over night
SP:SAMPLEPREP_SUMMARY            	at room temperature and stored at -40˚C until further analysis. The dried
SP:SAMPLEPREP_SUMMARY            	extracts were reconstituted in 100 μl of water/acetonitrile (ACN)/isopropanol
SP:SAMPLEPREP_SUMMARY            	(IPA), (v:v:v, 1:1:3,). The lipids were dissolved by vigorous vortexing for five
SP:SAMPLEPREP_SUMMARY            	minutes, followed by five minutes of sonication. This step was repeated three
SP:SAMPLEPREP_SUMMARY            	times to allow the dry extracts to thoroughly dissolve in the solvent. Samples
SP:SAMPLEPREP_SUMMARY            	were subsequently centrifuged at 21,000 rcf for 10 minutes at 4ºC and
SP:SAMPLEPREP_SUMMARY            	transferred to 150-μl glass inserts placed in glass vials (Waters).
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Acquity UPLC
CH:COLUMN_NAME                   	Waters Acquity C18 CSH (2.1 x 10 mm, 1.7 μm)
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
AN:ANALYSIS_PROTOCOL_FILE        	jli_20210217_034113_PR_MS_Methodology.docx
#MS
MS:INSTRUMENT_NAME               	Waters Synapt G2 S QTOF
MS:INSTRUMENT_TYPE               	QTOF
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	NEGATIVE
MS:MS_COMMENTS                   	refer to Methodology.docx
MS:MS_RESULTS_FILE               	ST001707_AN002781_Results.txt	UNITS:peak area	Has m/z:Yes	Has RT:Yes	RT units:Seconds
#END